It was a bit of a rollercoaster ride for the Northwest Biotherapeutics (OTC: NWBO) stock on Friday despite there being no specific news about the company.
At the beginning of the trading session, the stock declined by as low as 6% but ended the day with gains of 4%. In this regard, it might be a good move for investors to take a closer look at a key development from earlier on this month.
Back on April 1, Northwest announced that it had successfully managed to complete the development of the production facility at its new plant located in Sawston, United Kingdom. It is a major development for Northwest since it is going to boost its production capabilities considerably. On top of that, it is also going to allow the company to move its operations from its current location in London, which consists of a cleanroom. Investors could consider keeping the stock in their watch lists at this point.
Writing for business and finance publishers has become his passion over the last decades after he completed a master’s degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.